Cargando…

Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset

BACKGROUND: The differential influence and outcome of various risk factors on occurrence of COVID-19 among patients with autoimmune rheumatic diseases (AIRD) during different COVID-19 peaks is underreported. AIM: To assess the impact and outcome of conventional risk factors, immunosuppressants, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jain, Vikramraj, Shobha, Vineeta, Kumar, Sharath, Janardana, Ramya, Selvam, Sumithra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628883/ https://www.ncbi.nlm.nih.gov/pubmed/37941863 http://dx.doi.org/10.31138/mjr.20230827.co

Ejemplares similares

Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset
por: Chebbi, Pramod, et al.
Publicado: (2023)

A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
por: Patil, Abhishek, et al.
Publicado: (2022)

Timing of tofacitinib therapy is critical to improving outcomes in severe-critical COVID-19 infection: A retrospective study from a tertiary care hospital
por: Kodali, Ramya, et al.
Publicado: (2022)

The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence
por: Geurts-Voerman, Gerlienke E., et al.
Publicado: (2020)

Aird: a computation-oriented mass spectrometry data format enables a higher compression ratio and less decoding time
por: Lu, Miaoshan, et al.
Publicado: (2022)

Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR)
por: Kavadichanda, Chengappa, et al.
Publicado: (2021)

Differences between First wave and Second wave of COVID-19 in India
por: Jain, Vijay Kumar, et al.
Publicado: (2021)

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
por: Kawano, Yumeko, et al.
Publicado: (2022)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
por: Mehta, Pankti, et al.
Publicado: (2022)

COVID-19: The Second Wave—Are There Lessons from the First Wave to Prepare Us for the Second Wave?
por: Kohli, Anirudh
Publicado: (2021)

Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
por: Menon, Aparna R., et al.
Publicado: (2022)

Curcumin in Autoimmune and Rheumatic Diseases
por: Yang, Melissa, et al.
Publicado: (2019)

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases
por: Jankowska, Katarzyna, et al.
Publicado: (2023)

Addendum: Aird, S.D. et al. Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa. Toxins 2017, 9(6), 187
por: Aird, Steven D., et al.
Publicado: (2018)

Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry
por: Strickland, Faith M, et al.
Publicado: (2016)

Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)

Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases
por: Ye, Shuang, et al.
Publicado: (2016)

Targeting Syk in Autoimmune Rheumatic Diseases
por: Deng, Guo-Min, et al.
Publicado: (2016)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Pneumococcal vaccination in autoimmune rheumatic diseases
por: Rákóczi, Éva, et al.
Publicado: (2017)

Mechanisms of hypertension in autoimmune rheumatic diseases
por: Taylor, Erin B., et al.
Publicado: (2019)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
por: Nirk, Eliise Laura, et al.
Publicado: (2020)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

Cognitive dysfunction in autoimmune rheumatic diseases
por: Oláh, Csaba, et al.
Publicado: (2020)

Vitamin D and Autoimmune Rheumatic Diseases
por: Athanassiou, Lambros, et al.
Publicado: (2023)

Long COVID in autoimmune rheumatic diseases
por: Fedorchenko, Yuliya, et al.
Publicado: (2023)

Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis
por: Hedar, Ahmed M., et al.
Publicado: (2021)

India's Second COVID Wave: How is it different from the First Wave?
por: Kapoor, M., et al.
Publicado: (2022)

Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran
por: Sahebari, Maryam, et al.
Publicado: (2022)

COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project
por: Rutter, Megan, et al.
Publicado: (2023)

A RETROSPECTIVE COHORT STUDY OF PATIENTS IN THE ICU FOR COVID-19: A LOOK INTO THE DIFFERENCE BETWEEN THE FIRST AND THE SECOND WAVE
por: ALI, RUHMA, et al.
Publicado: (2021)

Stem cell transplantation for rheumatic autoimmune diseases
por: Hügle, Thomas, et al.
Publicado: (2008)

Genes, autoimmunity and pathogenesis of rheumatic heart disease
por: Guilherme, L, et al.
Publicado: (2011)

Why are women predisposed to autoimmune rheumatic diseases?
por: Oliver, Jacqueline E, et al.
Publicado: (2009)

Biotechnological Drugs: The Breakthrough in Autoimmune Rheumatic Conditions
por: Cavagna, Lorenzo, et al.
Publicado: (2014)

Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases
por: Shah, Ami A., et al.
Publicado: (2015)

Infections as a cause of autoimmune rheumatic diseases
por: Sakkas, Lazaros I., et al.
Publicado: (2016)

Role of inflammasomes in inflammatory autoimmune rheumatic diseases
por: Yi, Young-Su
Publicado: (2018)

Rheumatic autoimmune diseases in women and midlife health
por: Marder, Wendy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1arjqvpmburc3f9vlj7oo1imuk